About the Authors
- Ruben R. Bender
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Anke Muth
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Irene C. Schneider
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Thorsten Friedel
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Jessica Hartmann
-
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
- Andreas Plückthun
-
Affiliation Department of Biochemistry, University of Zurich, Zurich, Switzerland
- Andrea Maisner
-
Affiliation Institute for Virology (BMFZ), Philipps-University Marburg, Marburg, Germany
- Christian J. Buchholz
-
* E-mail: christian.buchholz@pei.de
Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: RRB and CJB are coinventors of a patent application including receptor-targeted NiV-LVs.
Author Contributions
Conceived and designed the experiments: RRB AMu ICS CJB. Performed the experiments: RRB AMu ICS TF. Analyzed the data: RRB AMu ICS TF JH AMa CJB. Contributed reagents/materials/analysis tools: JH AP AMa. Wrote the paper: RRB AP AMa CJB.